Published in G Chir on July 20, 2015
A modified sentinel node and occult lesion localization (SNOLL) technique in non-palpable breast cancer: a pilot study. J Exp Clin Cancer Res (2015) 0.75
Preoperative localization and radioguided parathyroid surgery. J Nucl Med (2003) 1.68
Minimally invasive parathyroidectomy facilitated by intraoperative nuclear mapping. Surgery (1997) 1.54
The 20% rule: a simple, instantaneous radioactivity measurement defines cure and allows elimination of frozen sections and hormone assays during parathyroidectomy. Surgery (1999) 1.37
Effect of lugol solution on thyroid gland blood flow and microvessel density in the patients with Graves' disease. J Clin Endocrinol Metab (2007) 1.36
Imaging techniques in parathyroid surgery for primary hyperparathyroidism. Am J Otolaryngol (2011) 1.20
A comprehensive overview of radioguided surgery using gamma detection probe technology. World J Surg Oncol (2009) 1.16
Role of gamma probes in performing minimally invasive parathyroidectomy in patients with primary hyperparathyroidism: optimization of preoperative and intraoperative procedures. Eur J Endocrinol (2003) 1.08
Importance of radio-guided minimally invasive parathyroidectomy using hand-held gamma probe and low (99m)Tc-MIBI dose. Technical considerations and long-term clinical results. Q J Nucl Med (2003) 0.87
Minimally invasive parathyroid surgery, the Norman 20% rule: is it valid? Am Surg (2011) 0.84
Measuring individual parathyroid gland hormone production in real-time during radioguided parathyroidectomy. Experience in over 8,000 operations. Minerva Endocrinol (2008) 0.82
High resolution mini-gammacamera and 99mTc [HMPAO] - leukocytes for diagnosis of infection and radioguided surgery in diabetic foot. G Chir (2005) 0.81
Epidermal growth factor receptor in human breast cancer: correlation with steroid hormone receptors and axillary lymph node involvement. Eur J Cancer Clin Oncol (1988) 3.92
Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. J Pharmacol Exp Ther (1994) 1.79
Increased levels of soluble P-selectin in hypercholesterolemic patients. Circulation (1998) 1.73
Concentrations of galectin-3 in the sera of normal controls and cancer patients. Clin Cancer Res (2000) 1.70
Endoglin: An accessory component of the TGF-beta-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies. J Cell Physiol (2001) 1.54
Endoluminal ultrasound for early detection of local recurrence of rectal cancer. Br J Surg (1989) 1.46
The natural history of spinal neurofibromatosis: a critical review of clinical and genetic features. Clin Genet (2014) 1.40
Miniaturized flow cytometry-based BCR-ABL immunoassay in detecting leptomeningeal disease. Leuk Res (2011) 1.40
Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties. Int J Cancer (2000) 1.33
Detection of antigens recognized by a novel monoclonal antibody in tissue and serum from patients with breast cancer. Cancer Res (1986) 1.24
Is the new WHO classification of neuroendocrine tumours useful for selecting an appropriate treatment? Ann Oncol (2005) 1.22
CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapy. J Clin Oncol (2000) 1.21
Galectin-3 overexpression protects from cell damage and death by influencing mitochondrial homeostasis. FEBS Lett (2000) 1.15
Neonatal problems of late and moderate preterm infants. Semin Fetal Neonatal Med (2012) 1.12
Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate. Eur J Cancer (1993) 1.10
Elevated serum levels of 90K/MAC-2 BP predict unresponsiveness to alpha-interferon therapy in chronic HCV hepatitis patients. J Hepatol (1996) 1.09
Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the Chronic Leukemia Working Party of the EBMT. Bone Marrow Transplant (2009) 1.07
Sick leave for follow-up control in thyroid cancer patients: comparison between stimulation with Thyrogen and thyroid hormone withdrawal. Eur J Endocrinol (2007) 1.06
Involvement of Fas-mediated apoptosis in the inhibitory effects of interferon-alpha in chronic myelogenous leukemia. Blood (1997) 1.04
Uremic autonomic neuropathy studied by spectral analysis of heart rate. Kidney Int (1999) 1.04
All-trans retinoic acid (ATRA) and the regulation of adhesion molecules in acute myeloid leukemia. Leuk Lymphoma (1996) 1.04
Effect of glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab. Eur J Neurol (2012) 1.00
Expression of myelomonocytic antigens is associated with unfavourable clinicoprognostic factors in B-cell chronic lymphocytic leukaemia. Ann Oncol (1991) 1.00
An ErbB-3 antibody, MP-RM-1, inhibits tumor growth by blocking ligand-dependent and independent activation of ErbB-3/Akt signaling. Oncogene (2011) 0.99
Glycoprotein 90K/MAC-2BP interacts with galectin-1 and mediates galectin-1-induced cell aggregation. Int J Cancer (2001) 0.99
The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants. Bone Marrow Transplant (2005) 0.98
MPO antibody-positive vasculitis in a patient with psoriatic arthritis and gold-induced membranous glomerulonephritis. Nephrol Dial Transplant (1998) 0.97
Survival and development of cardiovascular disease by modality of treatment in patients with end-stage renal disease. J Am Soc Nephrol (2001) 0.96
Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases. Br J Haematol (1998) 0.96
Morbidity and mortality on maintenance haemodialysis. Nephron (1998) 0.94
Patterns of K-ras mutation in colorectal carcinomas from Iran and Italy (a Gruppo Oncologico dell'Italia Meridionale study): influence of microsatellite instability status and country of origin. Ann Oncol (2006) 0.94
Physical forces and non linear dynamics mould fractal cell shape: quantitative morphological parameters and cell phenotype. Histol Histopathol (2013) 0.94
90K (Mac-2 BP) in human milk. Clin Exp Immunol (1996) 0.94
Suppression of tumor growth in vivo by local and systemic 90K level increase. Cancer Res (1995) 0.93
Effects of intermittent theta burst stimulation on spasticity in patients with multiple sclerosis. Eur J Neurol (2009) 0.93
Cardiovascular disease in chronic renal failure: the challenge continues. Registro Lombardo Dialisi e Trapianto. Nephrol Dial Transplant (2000) 0.93
Survival of prosthetic grafts of different materials after impairment of a native arteriovenous fistula in hemodialysis patients. ASAIO J (2001) 0.92
Peritoneal transport assessment by peritoneal equilibration test with 3.86% glucose: a long-term prospective evaluation. Kidney Int (2006) 0.92
Expression of the 67-kDa laminin receptor in acute myeloid leukemia cells mediates adhesion to laminin and is frequently associated with monocytic differentiation. Clin Cancer Res (1999) 0.91
Characterization of two novel cell lines, DERL-2 (CD56+/CD3+/Tcry5+) and DERL-7 (CD56+/CD3-/TCRgammadelta-), derived from a single patient with CD56+ non-Hodgkin's lymphoma. Leukemia (2001) 0.91
Circulating immunostimulatory protein 90K and soluble interleukin-2-receptor in human ovarian cancer. Int J Cancer (1996) 0.91
90K protein: a new predictor marker of disease progression in human immunodeficiency virus infection. J Acquir Immune Defic Syndr (1993) 0.90
Biochemistry of cervical mucus: a comparative analysis of the secretion from preovulatory, postovulatory, and pregnancy periods. Fertil Steril (1971) 0.90
Induced protein synthesis and oestradiol binding to the nuclei in the rat uterus. Nat New Biol (1973) 0.90
Polychromatic flow cytometry analysis of CD34+ hematopoietic stem cells in cryopreserved early preterm human cord blood samples. Cytometry A (2011) 0.90
Elevated plasma levels of 90K (Mac-2 BP) immunostimulatory glycoprotein in HIV-1-infected children. J Clin Immunol (2000) 0.90
Splenic injury as a complication of colonoscopy and polypectomy. Report of a case and review of the literature. Dis Colon Rectum (1987) 0.89
An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancer. Br J Cancer (2010) 0.89
Differential expression of CD54/intercellular adhesion molecule-1 in myeloid leukemias and in lymphoproliferative disorders. Blood (1990) 0.89
Blood cell flow cytometry in paroxysmal nocturnal hemoglobinuria: a tool for measuring the extent of the PNH clone. Leukemia (1996) 0.89
A 90-kDa protein serum marker for the prediction of progression to AIDS in a cohort of HIV-1+ homosexual men. AIDS Res Hum Retroviruses (1993) 0.89
Enhancement of cytosine arabinoside-induced apoptosis in human myeloblastic leukemia cells by NF-kappa B/Rel- specific decoy oligodeoxynucleotides. Gene Ther (2000) 0.89
Sex moderates circadian chemotherapy effects on survival of patients with metastatic colorectal cancer: a meta-analysis. Ann Oncol (2012) 0.89
Benefit and timing of second transplantations in multiple myeloma: clinical findings and methodological limitations in a European Group for Blood and Marrow Transplantation registry study. J Clin Oncol (2004) 0.89
Unknown primary tumors. Biochim Biophys Acta (2011) 0.88
The effect of parenteral nitrogen and energy intake on electrolyte balance in the preterm infant. Eur J Clin Nutr (2011) 0.88
Adhesion to 90K (Mac-2 BP) as a mechanism for lymphoma drug resistance in vivo. Blood (2000) 0.88
Antiproliferative effects of somatostatin and the somatostatin analog SMS 201-995 on three human breast cancer cell lines. J Cancer Res Clin Oncol (1988) 0.88
Search for compensation postures with videofluoromanometric investigation in dysphagic patients affected by amyotrophic lateral sclerosis. Radiol Med (2011) 0.88
90K (MAC-2 BP) gene expression in breast cancer and evidence for the production of 90K by peripheral-blood mononuclear cells. Int J Cancer (1998) 0.88
Human milk 90K (Mac-2 BP): possible protective effects against acute respiratory infections. Clin Exp Immunol (1999) 0.88
Epidermal growth factor receptor expression in gynecological malignancies. Gynecol Obstet Invest (1989) 0.88
Two new estrogen-supersensitive variants of the MCF-7 human breast cancer cell line. Breast Cancer Res Treat (1983) 0.87
Dynamic test with recombinant interferon-alpha-2b: effect on 90K and other tumour-associated antigens in cancer patients without evidence of disease. Br J Cancer (1993) 0.87
Early low-dose hydrocortisone in very preterm infants: a randomized, placebo-controlled trial. Neonatology (2006) 0.87
Glycosyl phosphatidylinositol (GPI)-anchored molecules and the pathogenesis of paroxysmal nocturnal hemoglobinuria. Crit Rev Oncol Hematol (2000) 0.87
Upregulation of epidermal growth factor receptor induced by alpha-interferon in human epidermoid cancer cells. Cancer Res (1991) 0.86
Increased tolerability of bimonthly 12-hour timed flat infusion 5-fluorouracil/irinotecan regimen in advanced colorectal cancer: A dose-finding study. Oncol Rep (2006) 0.85
Triplet schedule of weekly 5-fluorouracil and alternating irinotecan or oxaliplatin in advanced colorectal cancer: a dose-finding and phase II study. Oncol Rep (2010) 0.85
Treatment of renal angiomyolipoma: surgery versus angioembolization. G Chir (2013) 0.85
Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects. Genes Brain Behav (2009) 0.85
Prognostic value of a novel circulating serum 90K antigen in HIV-infected haemophilia patients. Br J Haematol (1993) 0.85
Combined treatment with steroids and azathioprine in IgA nephropathy: design of a prospective randomised multicentre trial. J Nephrol (2000) 0.84
Improvement of hand dexterity following motor cortex rTMS in multiple sclerosis patients with cerebellar impairment. Mult Scler (2008) 0.84
Sequential administration of recombinant human interleukin-2 and dacarbazine in metastatic melanoma: a multicenter phase II study. J Clin Oncol (1991) 0.84
90K (Mac-2 BP) predicts CD4 decline in human immunodeficiency virus-infected patients with CD4 counts above 200 x 10(6) cells/L. Arch Pathol Lab Med (1998) 0.84
Recombinant alpha-2b-interferon dynamic test as a potential tool in predicting disease status during second look in ovarian cancer. A preliminary report. Cancer (1991) 0.84
Combined videofluoroscopy and manometry in the diagnosis of oropharyngeal dysphagia: examination technique and preliminary experience. Radiol Med (2008) 0.84
Unusually high level of a tumor-associated antigen in the serum of human immunodeficiency virus-seropositive individuals. J Infect Dis (1991) 0.84
Splenic vein aneurysm: is it a surgical indication? J Vasc Surg (1999) 0.83
PARP co-activates B-MYB through enhanced phosphorylation at cyclin/cdk2 sites. Oncogene (2001) 0.83
Strong association between an HLA-DR antigen and thyroid carcinoma. Tissue Antigens (1982) 0.83
Effects of type-I and -II interferons on 90K antigen expression in ovarian carcinoma cells. Int J Cancer (1994) 0.83
Recombinant alpha-2b-interferon enhances the circulating levels of a 90-kilodalton (K) tumor-associated antigen in patients with gynecologic and breast malignancies. Cancer (1990) 0.83
[Seroma in residual fibrous capsule after breast implant explantation: a case report]. G Chir (2008) 0.82
Tumor-associated antigen 90K activates myelomonocytic cell line THP-1. Cancer Lett (1996) 0.82
Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant (2013) 0.82
Tyrosine kinase inhibitors. Curr Cancer Drug Targets (2010) 0.82
Differential expression and cytoplasm/membrane distribution of endoglin (CD105) in human tumour cell lines: Implications in the modulation of cell proliferation. Int J Oncol (2005) 0.82
Hemodialysis: yesterday, today and tomorrow. Minerva Urol Nefrol (2010) 0.82
Glucocorticoid receptors predict response to combination chemotherapy in patients with acute lymphoblastic leukemia. Oncology (1987) 0.82
Biochemical changes during progesterone-induced maturation in Xenopus laevis oocytes. Mol Cell Biochem (1974) 0.82
Human serum albumin cysteinylation is increased in end stage renal disease patients and reduced by hemodialysis: mass spectrometry studies. Free Radic Res (2013) 0.82
DNA and S-phase fraction analysis by flow cytometry in prostate cancer. Clinicopathologic implications. Cancer (1993) 0.82
High-dose (200 mg/m2) cisplatin-induced neurotoxicity in primary advanced ovarian cancer patients. Cancer Treat Rep (1987) 0.81
Role of proteinuria reduction in the progression of IgA nephropathy. Ren Fail (2001) 0.81
Immunohistochemical localization of creatine kinase BB in primary breast cancer: correlation with estrogen receptor content. J Cancer Res Clin Oncol (1988) 0.81
FOXN1 mutation abrogates prenatal T-cell development in humans. J Med Genet (2011) 0.81
Amyotrophic lateral sclerosis: sonographic evaluation of dysphagia. Radiol Med (2010) 0.81